Cargando...

The impact of design and performance in PSA screening: differences between ERSPC centers

The European Randomized study of Screening for Prostate Cancer (ERSPC) has shown a 20% relative reduction in prostate cancer mortality after 16 years (rate ratio RR 0.80), but centers varied by attendance, screen interval, biopsy compliance, contamination in the control arm and treatments. We used a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur Urol
Autores principales: Heijnsdijk, Eveline A.M., Adolfsson, Jan, Auvinen, Anssi, Roobol, Monique J., Hugosson, Jonas, de Koning, Harry J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6800079/
https://ncbi.nlm.nih.gov/pubmed/31031050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.04.007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!